Associate Professor Amanda Gwee MBBS FRACP DTMH PhD is the Leader of the Antimicrobials Group at the Murdoch Children's Research Institute. She is a general paediatrician, infectious diseases physician and clinical pharmacologist as well as the Clinical Lead of Research in the Department of General Medicine at the Royal Children’s Hospital Melbourne. In addition, she is an Associate Professor in the Department of Paediatrics, at the University of Melbourne.
Her research program focuses on optimising antimicrobial use and access in children and includes national and international clinical trials, pharmacokinetic/pharmacodynamic studies, and cohort studies. Amanda is passionate about improving medication use in children and is therefore involved in several international guideline/expert groups (European Society for Paediatric Infectious Diseases, WHO, Therapeutic Guidelines). She created and leads the Australasian KIDS DOSE consortium, a network of paediatric clinician researchers across 17 hospital/research institutions in Australia and New Zealand, dedicated to improving equity in access to optimal antimicrobial use in children.
Associate Professor Amanda Gwee MBBS FRACP DTMH PhD is the Leader of the Antimicrobials Group at the Murdoch Children's Research Institute. She is a general paediatrician, infectious diseases physician and clinical pharmacologist as well as the...
Associate Professor Amanda Gwee MBBS FRACP DTMH PhD is the Leader of the Antimicrobials Group at the Murdoch Children's Research Institute. She is a general paediatrician, infectious diseases physician and clinical pharmacologist as well as the Clinical Lead of Research in the Department of General Medicine at the Royal Children’s Hospital Melbourne. In addition, she is an Associate Professor in the Department of Paediatrics, at the University of Melbourne.
Her research program focuses on optimising antimicrobial use and access in children and includes national and international clinical trials, pharmacokinetic/pharmacodynamic studies, and cohort studies. Amanda is passionate about improving medication use in children and is therefore involved in several international guideline/expert groups (European Society for Paediatric Infectious Diseases, WHO, Therapeutic Guidelines). She created and leads the Australasian KIDS DOSE consortium, a network of paediatric clinician researchers across 17 hospital/research institutions in Australia and New Zealand, dedicated to improving equity in access to optimal antimicrobial use in children.
Top Publications
Lawrence, J, Gwee, A, Quinlan, C.
Pneumococcal haemolytic uraemic syndrome in the postvaccine era.
Archives of Disease in Childhood
103(10)
:
957
2018
view publication
Wilkins, AL, Steer, AC, Cranswick, N, Gwee, A.
Question 1: Is it safe to use ivermectin in children less than five years of age and weighing less than 15 kg?.
Archives of Disease in Childhood
103(5)
:
514
2018
view publication
Andrew, EC, Curtis, N, Coghlan, B, Cranswick, N, Gwee, A.
Adverse effects of amphotericin B in children; a retrospective comparison of conventional and liposomal formulations.
British Journal of Clinical Pharmacology
84(5)
:
1006 -1012
2018
view publication
van den Heuvel, N, O'Leary, C, Gwee, A.
Meningococcal Meningitis Complicated by Ventriculitis in an Infant.
Journal of Paediatrics and Child Health
54(2)
:
213 -214
2018
view publication
Boast, A, Gwee, A, Gwee, A.
Teicoplanin—Should We Be Doing Routine Therapeutic Drug Monitoring in Children?.
The Pediatric Infectious Disease Journal
36(11)
:
1110
2017
view publication